Pharmaceutical dosage formulations of fenofibrate and their appl

Details Pharmaceutical dosage formulations of fenofibrate and their appl Pharmaceutical dosage formulations of fenofibrate and their appl

1996-07-25

1998-10-27

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424455, 424456, 514962, 514975, A61K 948

Patent

active

058275363

ABSTRACT:
Soluble fenofibrate (Rec. INN) formulations exhibiting a significantly improved bioavailability after oral administration ("superbioavailability"), a process for their production and medicaments comprising these formulations. The said fenofibrate pharmaceutical dosage formulations essentially contain fenofibrate in solution in a solubilizing agent consisting of a non-ionic surfactant, diethylene glycol monoethyl ether (DGME).

REFERENCES:
Chemical Abstracts, vol. 112, No. 8, Feb. 19, 1990 & 5th Congr. Int. Technol. Pharm., vol. 3, 1989, pp. 190-199. A. Ben-Amor et al., "Augmentation of the Bioavailability of a Hypolipemic Agent for Incorporation into a Liquid-Containing Gel".

Affiliated with

Also associated with

Rating

Pharmaceutical dosage formulations of fenofibrate and their appl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical dosage formulations of fenofibrate and their appl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage formulations of fenofibrate and their appl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1612081